Page last updated: 2024-09-03

kf 17837s and oxidopamine

kf 17837s has been researched along with oxidopamine in 1 studies

Compound Research Comparison

Studies
(kf 17837s)
Trials
(kf 17837s)
Recent Studies (post-2010)
(kf 17837s)
Studies
(oxidopamine)
Trials
(oxidopamine)
Recent Studies (post-2010) (oxidopamine)
39008,63062,407

Protein Interaction Comparison

ProteinTaxonomykf 17837s (IC50)oxidopamine (IC50)
Glyceraldehyde-3-phosphate dehydrogenaseHomo sapiens (human)8
DNA repair protein RAD52 homologHomo sapiens (human)0.779

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Koga, K; Kurokawa, M; Kuwana, Y; Nakamura, J; Ochi, M1

Other Studies

1 other study(ies) available for kf 17837s and oxidopamine

ArticleYear
Adenosine A(2A) receptor antagonists KF17837 and KW-6002 potentiate rotation induced by dopaminergic drugs in hemi-Parkinsonian rats.
    European journal of pharmacology, 2000, Nov-24, Volume: 408, Issue:3

    Topics: Animals; Apomorphine; Behavior, Animal; Dopamine Agents; Dose-Response Relationship, Drug; Drug Synergism; Levodopa; Male; Oxidopamine; Parkinson Disease, Secondary; Purinergic P1 Receptor Antagonists; Purines; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A2A; Xanthines

2000